Abstract

The clinical applications of surgical robotics have advanced greatly over the past two decades. Intuitive Surgical and the da Vinci platform have been the dominant company and system commercially in the field of surgical robotics. In the past decade, robotic platforms have been introduced commercially for applications other than assisting a laparoscopic surgical approach. One such robotic platform is the Renaissance System from Mazor Robotics. This robotic platform differs greatly from the da Vinci platform and is focused on spine surgery and cranial surgery. This talk will provide a historical review of the genesis and maturation of the Renaissance platform, an overview of its current applications in spine surgery and neurosurgery, and a review of the current limitations of the system and potential areas for further development.

Bio

Christopher Prentice is Chief Executive Officer for Mazor Robotics Inc., the US subsidiary of Mazor Robotics Ltd. He received his B.S. degree in Systems Engineering from the United States Military Academy at West Point in 1992. He received his MBA in 1994 from Western New England University and his MHA in 2009 from the University of South Florida. His career in healthcare & medical devices began in 1997 and includes product management, marketing, sales, and finance roles with Ethicon Endo-Surgery, Intuitive Surgical, Tampa General Hospital, and Mazor Robotics. His product focus has been on laser, radiotherapy, and robotic platforms intended to advance the quality of surgical care.